Pavle S. Milutinovic, MD, PhD
Allergy and Immunology
Accepting new patients
Sees patients age 18 and up
Penn Allergy and Immunology University City
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)

Education and training

  • Medical School: University of Pittsburgh
  • Residency: Duke University Medical Center
  • Fellowship: National Institutes of Health

What my patients think about me

Average Rating

273 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
he's very thorough
October 2025
doctor was polite, listened and explained everything in a manner that i could understand
October 2025
very professional. efficient
October 2025
i have been with him for a little over 3 years and everything he has recommended is helping.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Milutinovic is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Timothy M Buckey, Priya J Patel, Pavle S Milutinovic Prevalence and clinical presentation of food protein-induced enterocolitis syndrome in an adult allergy/immunology clinic , Ann Allergy Asthma Immunol, 133(2): 2024,222-223


Timothy Buckey, MD, Priya Patel, MD, Pavle Milutinovic, MD PhD On the Differential: Presentation and Prevalence of Adult Food Protein-Induced Enterocolitis Syndrome , The Journal of Allergy and Clinical Immunology, 153(2): 2024,AB195


Morabito KM, Milutinovic P, Graham BS, Pierson TC. Zika Virus Vaccines (Chapter 65) , Plotkin's Vaccines, Eighth Edition: 2022


VanBlargan LA, Milutinovic PS, Goo L, DeMaso CR, Durbin AP, Whitehead SS, Pierson TC, Dowd KA. Dengue virus serotype 1 conformational dynamics confers virus strain-dependent patterns of neutralization by polyclonal sera. , J Virol. , 95(23): 2021,e0095621


Milutinovic PS, Maciejewski S, Dowd KA, Graham BS, Pierson TC. Impact of residues in the Zika virus E protein stem and transmembrane region on the antigenic structure of virus particles. , American Society for Virology (ASV) 39th Annual Meeting, Fort Collins, CO, : 2020


Perkins TN, Oczypok EA, Milutinovic PS, Dutz RE, Oury TD. RAGE-dependent VCAM-1 expression in the lung endothelium mediates IL-33 induced allergic airway inflammation. , Allergy. , 74(1): 2018,89-99


Oczypok EA*, Milutinovic PS*, Alcorn JF, Khare A, Crum LT, Manni ML, Epperly MW, Pawluk AM, Ray A, Oury TD. *first co-authors Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. , J Allergy Clin Immunol. , 136(3): 2015,747-756


Milutinovic PS, Englert JM, Crum LT, Mason NS, Ramsgaard L, Enghild JJ, Sparvero LJ, Lotze MT, Oury TD. Clearance Kinetics and Matrix Binding Partners of the Receptor for Advanced Glycation End Products. , PLOS One. , 9(3): 2014,e88259


Milutinovic PS, Alcorn J, Englert J, Crum L, Oury T. The Receptor For Advanced Glycation End- Products Is A Central Mediator Of Asthma Pathogenesis. , Am J Pathol. , 181(4): 2012,1215-1225


Ramsgaard L, Englert JM, Manni ML, Milutinovic PS, Gefter J, Tobolewski J, Crum L, Coudriet GM, Piganelli J, Zamora R, Vodovotz Y, Enghild JJ, Oury TD. Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice. , PLOS One. , 6(5): 2011,e20132